Eric Green is the outgoing President and Chief Executive Officer of West Pharmaceutical Services, the Pennsylvania-based injectable drug delivery specialist. He announced his planned retirement in March 2026 after 11 years leading the company, and is succeeded by Michel Lagarde effective 31 August 2026.
During Green's tenure West more than doubled sales and generated approximately 350% total shareholder return. He also held the Board Chair position, which was separated from the chief executive role on his departure, with Lead Independent Director Robert Friel assuming the chair.
Career History
- President and Chief Executive Officer, West Pharmaceutical Services (2015 to 2026)
- Board Chair, West Pharmaceutical Services (to 2026)
What Eric Green leaves at West Pharmaceutical Services: an 11-year record in which sales more than doubled and total shareholder return reached approximately 350%, and a succession plan he remains supportive of.
Facts compiled by Executive Moves from publicly available news and press releases on 16 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you Eric Green?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →
